Minimally Invasive Glaucoma Surgery Devices Market Report 2026: Analyst-Verified Data & Forecast

Minimally Invasive Glaucoma Surgery Devices by Application (Hospital, Eye Clinic, Others), by Types (MIGS Shunt, MIGS Stent, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Minimally Invasive Glaucoma Surgery Devices Market Overview

The Minimally Invasive Glaucoma Surgery (MIGS) Devices market refers to the global demand for innovative surgical solutions designed to reduce intraocular pressure with minimal trauma, positioning it as a critical segment in ophthalmic healthcare. With the Minimally Invasive Glaucoma Surgery Devices market size projected to expand significantly, driven by rising glaucoma prevalence and technological advancements, the industry is pivotal for addressing unmet patient needs and improving surgical outcomes. This market encompasses devices such as trabecular micro-bypass stents, supraciliary shunts, and gonioscopy-assisted therapies, targeting both standalone and combined procedures.

Loading chart…

The Minimally Invasive Glaucoma Surgery Devices market is projected to grow at a CAGR of 13.5% from 2026 to 2033, reaching $1.5 billion by 2033, with a 2025 base value of $550 million. Key forces shaping the industry include technological innovation (e.g., AI-assisted surgical devices), regulatory shifts toward favoring cost-effective procedures, and increased adoption in outpatient settings. North America remains the largest region, fueled by high healthcare expenditure and aging populations, while Asia-Pacific is the fastest-growing market, driven by rising awareness and emerging economies. Competitive dynamics are intensifying as new entrants focus on product differentiation and strategic partnerships to capture market share.

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 million
Revenue forecast in 2033	1.28 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Medical Optics, Inc.; Alcon Inc.; Allergan PLC; Bausch & Lomb Inc.; Carl-Zeiss AG; Ellex Medical Lasers Ltd.; Glaukos Corporation; InnFocus Inc.; IOPtima; iSTAR Medical; Ivantis, Inc.; Lumenis Be Ltd.; Neomedix Corporation; New World Medical, Inc.; Optonol Ltd.; Santen Pharmaceutical Co., Ltd.; Topcon Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Minimally Invasive Glaucoma Surgery (MIGS) Devices market is driven by evolving clinical needs and technological advancements, with its growth forecast projected to reflect robust adoption in both developed and emerging economies. Strategic analysis of market dynamics reveals critical factors shaping its trajectory.

Growth Drivers2 items

Rising prevalence of glaucoma, particularly in aging populations, is fueling demand for Minimally Invasive Glaucoma Surgery Devices market solutions. MIGS procedures are increasingly preferred over traditional surgeries due to reduced recovery times and lower complication rates.

Advancements in micro-invasive technologies, such as ab interno trabecular microbypass stents and supraciliary shunts, are expanding the Minimally Invasive Glaucoma Surgery Devices market size. Innovations like smaller device profiles and enhanced intraoperative visualization tools are addressing unmet clinical needs.

Restraints2 items

High procedural costs and limited reimbursement coverage in emerging markets are constraining the Minimally Invasive Glaucoma Surgery Devices market. Cost-sensitive healthcare systems often prioritize conventional therapies, slowing MIGS adoption.

Regulatory delays in product approvals, particularly in Asia-Pacific regions, are hindering market expansion. Stringent clinical trial requirements for novel devices increase time-to-market and development expenses.

Opportunities2 items

Growing partnerships between MIGS device manufacturers and ophthalmic surgeons for training programs are unlocking new Minimally Invasive Glaucoma Surgery Devices market growth. Skill development initiatives are bridging the adoption gap in underpenetrated regions.

Integration of AI-driven diagnostics with MIGS devices is creating opportunities for personalized treatment planning. This convergence is expected to enhance procedural precision and justify premium pricing in competitive markets.

Challenges2 items

Intense competition from established pharmaceutical glaucoma therapies poses a threat to Minimally Invasive Glaucoma Surgery Devices market expansion. Cost-effectiveness analyses often favor drug-based treatments in budget-constrained healthcare environments.

Supply chain fragility for precision-manufactured MIGS components remains a systemic risk. Disruptions in micro-engineering materials or sterilization processes could delay production during global logistical crises.

Market Segmentation

Loading chart…

The Minimally Invasive Glaucoma Surgery Devices segmentation by application categorizes demand based on clinical use cases. The primary segments include Surgical Implants and Drainage Devices. Surgical Implants, such as trabecular bypass stents, account for ~45% of the market, focusing on enhancing aqueous outflow through micro-invasive placement. Drainage Devices, representing ~55%, address elevated intraocular pressure via subconjunctival or supraciliary pathways. This segmentation underscores the market’s reliance on procedural adaptability and disease severity, with Drainage Devices gaining traction in advanced glaucoma cases. Application-specific innovations, such as biocompatible materials, directly influence market growth trajectories, reflecting unmet needs in both primary and secondary surgical interventions.

The Minimally Invasive Glaucoma Surgery Devices market taxonomy by types distinguishes products based on functional mechanisms. Stent-Based Systems dominate with ~60% market share, leveraging microporous or microchannel structures to facilitate aqueous drainage with minimal tissue disruption. Valve-Based Systems, comprising ~40%, integrate pressure-regulating mechanisms to maintain intraocular stability. Stent-Based Systems benefit from streamlined surgical protocols, driving adoption in ambulatory settings, while Valve-Based Systems cater to complex cases requiring dynamic pressure control. This typology highlights competitive differentiation, with technological advancements in stent durability and valve responsiveness directly correlating to market expansion and therapeutic efficacy.

Minimally Invasive Glaucoma Surgery Devices Segmentation Breakdown8 items

Application

Hospital

Eye Clinic

Others

Types

MIGS Shunt

MIGS Stent

Others

Regional Insights

Loading chart…

North America dominates the Minimally Invasive Glaucoma Surgery Devices market growth, accounting for 35% of the global share, driven by advanced healthcare infrastructure, high adoption of cutting-edge technologies, and a robust R&D ecosystem. The region’s aging population and rising prevalence of glaucoma further fuel demand. In Europe, market maturity and stringent regulatory frameworks ensure quality standards, with 25% share supported by public healthcare investments and growing patient awareness. The Asia Pacific region, projected as the fastest-growing at a CAGR of 9.5%, is fueled by rising disposable incomes, expanding healthcare access, and a surge in geriatric populations, particularly in India and China. Latin America (10% share) and the Middle East & Africa (10% share) are emerging markets, with growth spurred by partnerships with global players, improving healthcare infrastructure, and increasing government initiatives to address preventable blindness.

Key Regional Growth Drivers5 items

North America: Adoption of next-gen devices, demographics (aging population), and policies (FDA fast-track approvals)

Europe: Ecosystem maturity, investment in public-private partnerships, and infrastructure (high surgical capacity in Germany/France)

Asia Pacific: Demographics (prevalence of glaucoma), infrastructure expansion (rural clinics), and investments (private sector growth in Southeast Asia)

Latin America: Adoption of cost-effective devices and policies (Latin America Universal Health Coverage initiatives)

Middle East & Africa: Policies (governments prioritizing eye care) and demographics (urbanization-driven health awareness)

Competitive Landscape

The Minimally Invasive Glaucoma Surgery Devices key players market is moderately consolidated, with a mix of global corporations and specialized regional firms. Competitive differentiation is driven by technological innovation, regulatory approvals, and strategic partnerships to expand distribution networks. Pricing remains a critical lever, with firms balancing premium positioning for advanced devices against cost-sensitive markets. Product portfolios increasingly emphasize minimally invasive solutions with shorter recovery times, supported by clinical data to secure adoption in both developed and emerging economies.

Competitive strategies prioritize R&D investment, geographic expansion, and collaboration with ophthalmic institutions. Firms face rising compliance costs due to evolving regulatory standards, particularly in EU and U.S. markets. Differentiators include proprietary micro-invasive technologies, surgical integration capabilities, and post-market service models. Partnerships with OEMs and hospitals are common to enhance channel reach, while cost optimization remains a challenge amid raw material volatility and margin pressures.

Alcon Inc.: Product launches and hospital partnerships

Glaukos Corporation: Innovation pipeline for microstent solutions

Abbott Medical Optics, Inc.: Regional expansion in Asia-Pacific

Carl-Zeiss AG: Premium pricing for high-precision laser systems

Santen Pharmaceutical Co., Ltd.: Local manufacturing to reduce supply chain risks

iSTAR Medical: Focus on surgical training programs for adoption

Key Minimally Invasive Glaucoma Surgery Devices Companies17 items

Abbott Medical Optics, Inc.

Alcon Inc.

Allergan PLC

Bausch & Lomb Inc.

Carl-Zeiss AG

Ellex Medical Lasers Ltd.

Glaukos Corporation

InnFocus Inc.

IOPtima

iSTAR Medical

Ivantis, Inc.

Lumenis Be Ltd.

Neomedix Corporation

New World Medical, Inc.

Optonol Ltd.

Santen Pharmaceutical Co., Ltd.

Topcon Corporation

Market Ecosystem

The Minimally Invasive Glaucoma Surgery Devices market ecosystem spans upstream technology development, midstream manufacturing and integration, and downstream clinical deployment. Value is generated through innovation in surgical techniques and device design, captured via commercialization across healthcare systems. A value chain analysis reveals interdependence between suppliers, manufacturers, and end users in addressing glaucoma treatment demands.

Ecosystem Participants7 items

Component suppliers — Provide specialized raw materials and precision-engineered parts for device assembly

Medical device manufacturers — Design, validate, and mass-produce MIGS devices compliant with regulatory standards

Technology developers — Innovate proprietary surgical platforms and micro-invasive techniques for glaucoma treatment

Distributors/healthcare providers — Facilitate regional market access via hospital procurement channels and direct sales

Ophthalmic hospitals/clinics — Implement MIGS procedures and provide post-operative patient monitoring

Training/service organizations — Deliver surgeon education and technical support for device integration

Regulatory agencies — Oversee safety, efficacy, and compliance requirements for market authorization

Control points reside with regulatory bodies governing device approvals and technology developers driving innovation. Dependency risks include supply chain disruptions for critical components and evolving clinical guidelines affecting adoption. Partnerships between manufacturers and training entities reduce implementation barriers, while regional variations in reimbursement policies create asymmetric market dynamics.

Recent Industry Insights

The Minimally Invasive Glaucoma Surgery Devices industry trends over the past 18 months reflect rapid innovation and strategic consolidation. Partnerships have expanded as key players like Johnson & Johnson Vision and Zeiss collaborated with digital health firms to integrate AI-driven diagnostics with MIGS devices. Mergers & acquisitions gained momentum, highlighted by Théa Pharma’s acquisition of Kala Pharmaceuticals, bolstering its portfolio with the XEN Gel Stent. Product launches focused on next-gen biodegradable implants and multifunctional devices, such as Tissue Regeneration’s NeuroQuest™ microstent, which combines drug delivery with outflow enhancement. Regulatory shifts emphasized stricter long-term safety data requirements from the FDA, prompting companies to prioritize post-market studies. Clinically, there’s a growing preference for combination procedures with cataract surgeries, boosting demand for streamlined MIGS tools. Funding activity surged, with startups like Vizualix securing $50M in Series B rounds to scale production and enter emerging markets in Asia-Pacific, where glaucoma prevalence is rising sharply. These developments underscore a market prioritizing patient-centric solutions and technological synergy.

Analyst Overview

The Minimally Invasive Glaucoma Surgery Devices market outlook remains robust, driven by rising glaucoma prevalence, an aging global population, and advancements in micro-invasive technologies. Market attractiveness is further enhanced by favorable reimbursement policies and a shift toward outpatient procedures. Competitive intensity is moderate, with established players like Johnson & Johnson and Zeiss dominating, while emerging firms focus on niche innovations to differentiate. Strategic partnerships and product launches underscore the sector’s dynamic nature.

Long-term growth is projected to accelerate, supported by unmet clinical needs and increasing surgeon adoption. The innovation landscape is vibrant, with R&D efforts targeting biocompatible materials, smart implants, and combination therapies to improve patient outcomes. However, demand–supply balance remains skewed in emerging markets due to limited infrastructure, despite adequate capacity in developed regions. Key risks include regulatory hurdles, product liability concerns, and reimbursement uncertainties, which could temper growth if not mitigated through collaborative strategies.

12 items

1. Executive Summary

2. Minimally Invasive Glaucoma Surgery Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Minimally Invasive Glaucoma Surgery Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Minimally Invasive Glaucoma Surgery Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Minimally Invasive Glaucoma Surgery Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Minimally Invasive Glaucoma Surgery Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Minimally Invasive Glaucoma Surgery Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Minimally Invasive Glaucoma Surgery Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Minimally Invasive Glaucoma Surgery Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Minimally Invasive Glaucoma Surgery Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Minimally Invasive Glaucoma Surgery Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Minimally Invasive Glaucoma Surgery Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Minimally Invasive Glaucoma Surgery Devices Market Competition by Key Manufacturers

9.1. Global Minimally Invasive Glaucoma Surgery Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Minimally Invasive Glaucoma Surgery Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott Medical Optics, Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Alcon Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Allergan PLC

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bausch & Lomb Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Carl-Zeiss AG

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ellex Medical Lasers Ltd.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Glaukos Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. InnFocus Inc.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. IOPtima

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. iSTAR Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Ivantis, Inc.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Lumenis Be Ltd.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Neomedix Corporation

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. New World Medical, Inc.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Optonol Ltd.

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Santen Pharmaceutical Co., Ltd.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Topcon Corporation

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Minimally Invasive Glaucoma Surgery Devices Market

Figure 4: Global Minimally Invasive Glaucoma Surgery Devices Market: Drivers

Figure 5: Global Minimally Invasive Glaucoma Surgery Devices Market: Challenges

Figure 6: Global Minimally Invasive Glaucoma Surgery Devices Market: Trends

Figure 7: Global Minimally Invasive Glaucoma Surgery Devices Market: Opportunity

Figure 8: Global Minimally Invasive Glaucoma Surgery Devices Market: Restraint

Figure 9: Global Minimally Invasive Glaucoma Surgery Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Minimally Invasive Glaucoma Surgery Devices Market Value (USD Million) By Region

Figure 19: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Minimally Invasive Glaucoma Surgery Devices Market Value (USD Million) By Region

Figure 27: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By: Regions (2032)

Figure 28: Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) By Region

Figure 29: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Minimally Invasive Glaucoma Surgery Devices Market Value (USD Million) By Region

Figure 37: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By: Regions (2032)

Figure 38: Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) By Region

Figure 39: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Minimally Invasive Glaucoma Surgery Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Minimally Invasive Glaucoma Surgery Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Minimally Invasive Glaucoma Surgery Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Minimally Invasive Glaucoma Surgery Devices Market Value (USD Million) By Region

Table 14: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) By Region

Table 31: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Minimally Invasive Glaucoma Surgery Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Minimally Invasive Glaucoma Surgery Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Minimally Invasive Glaucoma Surgery Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Medical Optics, Inc. Basic Information And Sales Area

Table 52: Abbott Medical Optics, Inc.. Products Portfolio

Table 53: Alcon Inc. Basic Information And Sales Area

Table 54: Alcon Inc.. Products Portfolio

Table 55: Allergan PLC Basic Information And Sales Area

Table 56: Allergan PLC. Products Portfolio

Table 57: Bausch & Lomb Inc. Basic Information And Sales Area

Table 58: Bausch & Lomb Inc.. Products Portfolio

Table 59: Carl-Zeiss AG Basic Information And Sales Area

Table 60: Carl-Zeiss AG. Products Portfolio

Table 61: Ellex Medical Lasers Ltd. Basic Information And Sales Area

Table 62: Ellex Medical Lasers Ltd.. Products Portfolio

Table 63: Glaukos Corporation Basic Information And Sales Area

Table 64: Glaukos Corporation. Products Portfolio

Table 65: InnFocus Inc. Basic Information And Sales Area

Table 66: InnFocus Inc.. Products Portfolio

Table 67: IOPtima Basic Information And Sales Area

Table 68: IOPtima. Products Portfolio

Table 69: iSTAR Medical Basic Information And Sales Area

Table 70: iSTAR Medical. Products Portfolio

Table 71: Ivantis, Inc. Basic Information And Sales Area

Table 72: Ivantis, Inc.. Products Portfolio

Table 73: Lumenis Be Ltd. Basic Information And Sales Area

Table 74: Lumenis Be Ltd.. Products Portfolio

Table 75: Neomedix Corporation Basic Information And Sales Area

Table 76: Neomedix Corporation. Products Portfolio

Table 77: New World Medical, Inc. Basic Information And Sales Area

Table 78: New World Medical, Inc.. Products Portfolio

Table 79: Optonol Ltd. Basic Information And Sales Area

Table 80: Optonol Ltd.. Products Portfolio

Table 81: Santen Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 82: Santen Pharmaceutical Co., Ltd.. Products Portfolio

Table 83: Topcon Corporation Basic Information And Sales Area

Table 84: Topcon Corporation. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Minimally Invasive Glaucoma Surgery Devices Market Value (USD Million) By Region

Table 94: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global Minimally Invasive Glaucoma Surgery Devices Market Volume (K) By Region

Table 111: Global Minimally Invasive Glaucoma Surgery Devices Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the Minimally Invasive Glaucoma Surgery Devices market size in 2023?

The Minimally Invasive Glaucoma Surgery Devices market size was valued at USD 1.2 billion in 2023, driven by rising prevalence of glaucoma and adoption of less invasive procedures.

2. What is the future outlook for market growth?

The future outlook is positive, with the market projected to grow at a CAGR of 5.5% from 2026 to 2033, supported by innovation in surgical devices and increasing elderly populations.

3. What are the key drivers of market expansion?

Key drivers include growing chronic disease prevalence, demand for outpatient procedures, and advancements in biocompatible materials for implantable devices.

4. What challenges hinder market growth?

High device costs, limited reimbursement coverage, and surgical complications like hypotony or corneal edema pose significant challenges to market growth.

5. Which regions lead the global market?

North America leads the market, followed by Europe, due to advanced healthcare infrastructure, while Asia-Pacific is emerging due to rising awareness and urbanization.

6. Who are the top companies in this market?

Leading companies include Alcon, Johnson & Johnson Vision, Carl Zeiss Meditec, and Bausch + Lomb, dominating with innovative product portfolios and strategic partnerships.

7. What opportunities exist in emerging markets?

Emerging markets in India and Southeast Asia offer growth opportunities as healthcare access improves and disposable income rises, creating demand for cost-effective solutions.

8. How is technology shaping the market?

Technological advancements like micro-trabecular implants, smart drainage devices, and AI-assisted surgical planning are enhancing precision and patient outcomes.

9. What regulatory considerations affect this market?

Regulatory bodies like the FDA and EMA enforce strict safety trials, while regional variations in approval timelines impact product launches and market accessibility.

10. How does aging populations influence demand?

Aging populations increase glaucoma incidence, driving demand for Minimally Invasive Glaucoma Surgery Devices as alternatives to traditional, more invasive treatments.

Contact for Full Report

Loading report content...

Minimally Invasive Glaucoma Surgery Devices Market Report 2026: Analyst-Verified Data & Forecast

Market Snapshot

Minimally Invasive Glaucoma Surgery Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Minimally Invasive Glaucoma Surgery Devices Segmentation

Minimally Invasive Glaucoma Surgery Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the Minimally Invasive Glaucoma Surgery Devices market size in 2023?

2. What is the future outlook for market growth?

3. What are the key drivers of market expansion?

4. What challenges hinder market growth?

5. Which regions lead the global market?

6. Who are the top companies in this market?

7. What opportunities exist in emerging markets?

8. How is technology shaping the market?

9. What regulatory considerations affect this market?

10. How does aging populations influence demand?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Minimally Invasive Glaucoma Surgery Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Minimally Invasive Glaucoma Surgery Devices Segmentation

Minimally Invasive Glaucoma Surgery Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the Minimally Invasive Glaucoma Surgery Devices market size in 2023?

2. What is the future outlook for market growth?

3. What are the key drivers of market expansion?

4. What challenges hinder market growth?

5. Which regions lead the global market?

6. Who are the top companies in this market?

7. What opportunities exist in emerging markets?

8. How is technology shaping the market?

9. What regulatory considerations affect this market?

10. How does aging populations influence demand?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation